Demystifying lymphedema: development of the lymphedema putting evidence into practice card.
Identifieur interne : 003056 ( PubMed/Corpus ); précédent : 003055; suivant : 003057Demystifying lymphedema: development of the lymphedema putting evidence into practice card.
Auteurs : Ellen Poage ; Marybeth Singer ; Jane Armer ; Melanie Poundall ; M Jeanne ShellabargerSource :
- Clinical journal of oncology nursing [ 1092-1095 ] ; 2008.
English descriptors
- KwdEn :
- MESH :
- complications : Lymphedema, Neoplasms.
- manpower : Oncology Nursing.
- physiopathology : Lymphedema.
- therapy : Lymphedema, Neoplasms.
- Evidence-Based Nursing, Humans, Risk Reduction Behavior.
Abstract
Cancer treatment is the leading cause of lymphedema in developed countries. Development and severity of lymphedema have a significant impact on comfort, psychological distress, and overall quality of life. Incidence statistics have ranged from 5%-60%, with onset of symptoms ranging from immediately after treatment to 30 years after treatment. Oncology nurses caring for patients throughout the cancer trajectory have a critical role to play in early assessment of risk, prompt identification of lymphedema, and implementation of evidence-based, individualized treatment plans in collaboration with therapists. As part of an Oncology Nursing Society (ONS) project team, the authors of this article undertook a review of current literature to identify effective interventions for the treatment of secondary lymphedema. Following the guidelines established by the ONS Evidence-Based Practice Resource Team, the authors evaluated current clinical practice guidelines, systematic reviews, and research studies conducted since 1998. The team reviewed and synthesized the literature and developed evidence tables and a Putting Evidence Into Practice(R) (PEP) card. The data were reviewed by experts in the field of lymphedema management. The lymphedema ONS PEP card, a user-friendly, succinct summary of interventions, was released at the 33rd Annual ONS Congress in May 2008.
DOI: 10.1188/08.CJON.951-964
PubMed: 19064389
Links to Exploration step
pubmed:19064389Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Demystifying lymphedema: development of the lymphedema putting evidence into practice card.</title><author><name sortKey="Poage, Ellen" sort="Poage, Ellen" uniqKey="Poage E" first="Ellen" last="Poage">Ellen Poage</name><affiliation><nlm:affiliation>Rehabilitation Associates of Naples, Fort Myers, FL, USA. egpoage@mac.com</nlm:affiliation></affiliation></author><author><name sortKey="Singer, Marybeth" sort="Singer, Marybeth" uniqKey="Singer M" first="Marybeth" last="Singer">Marybeth Singer</name></author><author><name sortKey="Armer, Jane" sort="Armer, Jane" uniqKey="Armer J" first="Jane" last="Armer">Jane Armer</name></author><author><name sortKey="Poundall, Melanie" sort="Poundall, Melanie" uniqKey="Poundall M" first="Melanie" last="Poundall">Melanie Poundall</name></author><author><name sortKey="Shellabarger, M Jeanne" sort="Shellabarger, M Jeanne" uniqKey="Shellabarger M" first="M Jeanne" last="Shellabarger">M Jeanne Shellabarger</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:19064389</idno><idno type="pmid">19064389</idno><idno type="doi">10.1188/08.CJON.951-964</idno><idno type="wicri:Area/PubMed/Corpus">003056</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003056</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Demystifying lymphedema: development of the lymphedema putting evidence into practice card.</title><author><name sortKey="Poage, Ellen" sort="Poage, Ellen" uniqKey="Poage E" first="Ellen" last="Poage">Ellen Poage</name><affiliation><nlm:affiliation>Rehabilitation Associates of Naples, Fort Myers, FL, USA. egpoage@mac.com</nlm:affiliation></affiliation></author><author><name sortKey="Singer, Marybeth" sort="Singer, Marybeth" uniqKey="Singer M" first="Marybeth" last="Singer">Marybeth Singer</name></author><author><name sortKey="Armer, Jane" sort="Armer, Jane" uniqKey="Armer J" first="Jane" last="Armer">Jane Armer</name></author><author><name sortKey="Poundall, Melanie" sort="Poundall, Melanie" uniqKey="Poundall M" first="Melanie" last="Poundall">Melanie Poundall</name></author><author><name sortKey="Shellabarger, M Jeanne" sort="Shellabarger, M Jeanne" uniqKey="Shellabarger M" first="M Jeanne" last="Shellabarger">M Jeanne Shellabarger</name></author></analytic><series><title level="j">Clinical journal of oncology nursing</title><idno type="ISSN">1092-1095</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Evidence-Based Nursing</term><term>Humans</term><term>Lymphedema (complications)</term><term>Lymphedema (physiopathology)</term><term>Lymphedema (therapy)</term><term>Neoplasms (complications)</term><term>Neoplasms (therapy)</term><term>Oncology Nursing (manpower)</term><term>Risk Reduction Behavior</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lymphedema</term><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="manpower" xml:lang="en"><term>Oncology Nursing</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term><term>Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Evidence-Based Nursing</term><term>Humans</term><term>Risk Reduction Behavior</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cancer treatment is the leading cause of lymphedema in developed countries. Development and severity of lymphedema have a significant impact on comfort, psychological distress, and overall quality of life. Incidence statistics have ranged from 5%-60%, with onset of symptoms ranging from immediately after treatment to 30 years after treatment. Oncology nurses caring for patients throughout the cancer trajectory have a critical role to play in early assessment of risk, prompt identification of lymphedema, and implementation of evidence-based, individualized treatment plans in collaboration with therapists. As part of an Oncology Nursing Society (ONS) project team, the authors of this article undertook a review of current literature to identify effective interventions for the treatment of secondary lymphedema. Following the guidelines established by the ONS Evidence-Based Practice Resource Team, the authors evaluated current clinical practice guidelines, systematic reviews, and research studies conducted since 1998. The team reviewed and synthesized the literature and developed evidence tables and a Putting Evidence Into Practice(R) (PEP) card. The data were reviewed by experts in the field of lymphedema management. The lymphedema ONS PEP card, a user-friendly, succinct summary of interventions, was released at the 33rd Annual ONS Congress in May 2008.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19064389</PMID><DateCreated><Year>2008</Year><Month>12</Month><Day>09</Day></DateCreated><DateCompleted><Year>2009</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2015</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1092-1095</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2008</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical journal of oncology nursing</Title><ISOAbbreviation>Clin J Oncol Nurs</ISOAbbreviation></Journal><ArticleTitle>Demystifying lymphedema: development of the lymphedema putting evidence into practice card.</ArticleTitle><Pagination><MedlinePgn>951-64</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1188/08.CJON.951-964</ELocationID><Abstract><AbstractText>Cancer treatment is the leading cause of lymphedema in developed countries. Development and severity of lymphedema have a significant impact on comfort, psychological distress, and overall quality of life. Incidence statistics have ranged from 5%-60%, with onset of symptoms ranging from immediately after treatment to 30 years after treatment. Oncology nurses caring for patients throughout the cancer trajectory have a critical role to play in early assessment of risk, prompt identification of lymphedema, and implementation of evidence-based, individualized treatment plans in collaboration with therapists. As part of an Oncology Nursing Society (ONS) project team, the authors of this article undertook a review of current literature to identify effective interventions for the treatment of secondary lymphedema. Following the guidelines established by the ONS Evidence-Based Practice Resource Team, the authors evaluated current clinical practice guidelines, systematic reviews, and research studies conducted since 1998. The team reviewed and synthesized the literature and developed evidence tables and a Putting Evidence Into Practice(R) (PEP) card. The data were reviewed by experts in the field of lymphedema management. The lymphedema ONS PEP card, a user-friendly, succinct summary of interventions, was released at the 33rd Annual ONS Congress in May 2008.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Poage</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Rehabilitation Associates of Naples, Fort Myers, FL, USA. egpoage@mac.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>Marybeth</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Armer</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Poundall</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Shellabarger</LastName><ForeName>M Jeanne</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin J Oncol Nurs</MedlineTA><NlmUniqueID>9705336</NlmUniqueID><ISSNLinking>1092-1095</ISSNLinking></MedlineJournalInfo><CitationSubset>N</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Clin J Oncol Nurs. 2014;18 Suppl:68-79</RefSource><PMID Version="1">25427610</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D055318" MajorTopicYN="Y">Evidence-Based Nursing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009859" MajorTopicYN="N">Oncology Nursing</DescriptorName><QualifierName UI="Q000364" MajorTopicYN="N">manpower</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040242" MajorTopicYN="N">Risk Reduction Behavior</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>12</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>1</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>12</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19064389</ArticleId><ArticleId IdType="pii">T8085644Q0215808</ArticleId><ArticleId IdType="doi">10.1188/08.CJON.951-964</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003056 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 003056 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:19064389
|texte= Demystifying lymphedema: development of the lymphedema putting evidence into practice card.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:19064389" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |